Meredith C Mason1,2, Nader N Massarweh1,2,3, Aitua Salami1, Mark A Sultenfuss4, Daniel A Anaya1,2,3. 1. Houston VA Center for Innovations in Quality, Effectiveness and Safety (IQUEST), Michael E. DeBakey VA Medical Center, Houston, TX, USA. 2. Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA. 3. Operative Care Line, Michael E. DeBakey VA Medical Center, Houston, TX, USA. 4. Department of Radiology, Medical Care Line, Michael E. DeBakey VA Medical Center, Houston, TX, USA.
Abstract
BACKGROUND: Transarterial chemoembolization (TACE) is the most common treatment for patients with unresectable hepatocellular carcinoma (HCC). Post-embolization syndrome (PES) is a common post-TACE complication. The goal of this study was to evaluate PES as an early predictor of the long-term outcome. METHODS: A retrospective cohort study of HCC patients treated with TACE at a tertiary referral centre was performed (2008-2014). Patients were categorized on the basis of PES, defined as fever with or without abdominal pain within 14 days of TACE. The primary outcome was overall survival (OS). Multivariate Cox regression was done to examine the association between PES and OS. RESULTS: Among 144 patients, 52 (36.1%) experienced PES. The median follow-up for the cohort was 11.4 months. The median and 3-year OS rates were 16 months and 18% in the PES group versus 25 months and 41% in the non-PES group (log rank, P = 0.027). After multivariate analysis, patients with PES had a significantly increased risk of death [hazard ratio 2.0 (95%CI 1.2-3.3), P = 0.011]. CONCLUSIONS: PES is a common complication after TACE and is associated with a two-fold increased risk of death. Future studies should incorporate PES as a relevant early predictor of OS and examine the biological basis of this association.
BACKGROUND: Transarterial chemoembolization (TACE) is the most common treatment for patients with unresectable hepatocellular carcinoma (HCC). Post-embolization syndrome (PES) is a common post-TACE complication. The goal of this study was to evaluate PES as an early predictor of the long-term outcome. METHODS: A retrospective cohort study of HCCpatients treated with TACE at a tertiary referral centre was performed (2008-2014). Patients were categorized on the basis of PES, defined as fever with or without abdominal pain within 14 days of TACE. The primary outcome was overall survival (OS). Multivariate Cox regression was done to examine the association between PES and OS. RESULTS: Among 144 patients, 52 (36.1%) experienced PES. The median follow-up for the cohort was 11.4 months. The median and 3-year OS rates were 16 months and 18% in the PES group versus 25 months and 41% in the non-PES group (log rank, P = 0.027). After multivariate analysis, patients with PES had a significantly increased risk of death [hazard ratio 2.0 (95%CI 1.2-3.3), P = 0.011]. CONCLUSIONS:PES is a common complication after TACE and is associated with a two-fold increased risk of death. Future studies should incorporate PES as a relevant early predictor of OS and examine the biological basis of this association.
Authors: Thomas J Vogl; Johannes Lammer; Riccardo Lencioni; Katerina Malagari; Anthony Watkinson; Frank Pilleul; Alban Denys; Clara Lee Journal: AJR Am J Roentgenol Date: 2011-10 Impact factor: 3.959
Authors: Robert Martin; David Geller; Joseph Espat; David Kooby; Marty Sellars; Robert Goldstein; David Imagawa; Charles Scoggins Journal: Hepatogastroenterology Date: 2012 Jan-Feb
Authors: Beatrijs A Seinstra; Luc Defreyne; Bieke Lambert; Marnix G E H Lam; Helena M Verkooijen; Karel J van Erpecum; Bart van Hoek; Arian R van Erkel; Minneke J Coenraad; Imad Al Younis; Hans van Vlierberghe; Maurice A A J van den Bosch Journal: Trials Date: 2012-08-23 Impact factor: 2.279
Authors: K J Hartrumpf; S Marquardt; T Werncke; T Murray; M M Kirstein; A Vogel; F Wacker; T Rodt Journal: J Cancer Res Clin Oncol Date: 2018-07-14 Impact factor: 4.553
Authors: Ali Morshid; Khaled M Elsayes; Ahmed M Khalaf; Mohab M Elmohr; Justin Yu; Ahmed O Kaseb; Manal Hassan; Armeen Mahvash; Zhihui Wang; John D Hazle; David Fuentes Journal: Radiol Artif Intell Date: 2019-09-25